Treatment was initiated at 36 mg/day and patients continued with incremental raises of eighteen mg/day (36 to 108 mg/day) depending on Assembly specific improvement criteria with acceptable tolerability. At the final research pay a visit to, indicate transform scores (LS Signify, SEM) with the investigator rating over the AISRS demonstrated that CO